Showing results (61-70 of 69) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Blood Advances|June 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse post-transplantSusan DeWolf, Jason Kuttiyara, Paola Vinci, et al.Leukemia|November 6, 2022
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphomaAna Alarcon Tomas, Joshua A Fein, Shalev Fried, et al.Blood|April 7, 2019
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantationPhilippe Armand, Yi-Bin Chen, Robert A Redd, et al.Leukemia & Lymphoma|March 24, 2023
Myeloid sarcoma with <i>NPM1</i> mutation may be clinically and genetically distinct from AML with <i>NPM1</i> mutation: a study from the Bone Marrow Pathology GroupMaximiliano Ramia de Cap, Leo P Wu, Christian Hirt, et al.Blood Advances|September 10, 2021
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCTRoni Shouval, Joshua A Fein, Christina Cho, et al.Journal of Medicinal Chemistry|May 30, 2003
Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeysEric E Boros, Vicente Samano, John A Ray, et al.JCO Precision Oncology|January 23, 2023
Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology GroupMiguel D Cantu, Rashmi Kanagal-Shamanna, Sa A Wang, et al.Blood Advances|January 10, 2020
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantationMatthew J Frigault, Philippe Armand, Robert A Redd, et al.Nature Medicine|April 1, 2025
An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphomaSandeep S Raj, Teng Fei, Shalev Fried, et al.Pageof 7